Sort by
Refine Your Search
-
The International Max Planck Research School for Chemistry and Physics of Quantum Materials is a joint PhD program between the Max Planck Institute for Chemical Physics of Solids in Dresden
-
The International Max Planck Research School for Ultrafast Imaging and Structural Dynamics in Hamburg, Germany, offers a structured PhD program focusing on ultra-fast phenomena, X-ray physics and
-
programme aim to systematically unravel the mechanisms that allow the retina to successfully reconcile high energy demands with information processing capacity. For more details on projects and training
-
mechanisms. The overall goal of the research project is to develop process understanding and parametrizations that lead to improved, energetically consistent, climate models. Close collaboration with the other
-
advanced training provide doctoral researchers with a solid foundation for their theses. The emphasis on neuroimaging and computational modelling further strengthens this foundation and enables new types
-
, 65 %). The Institute of Pharmacology focuses on deciphering the molecular mechanisms that control regeneration as well as tumor initiation and progression in epithelial tissues. The PhD project aims
-
, 65 %). The Institute of Pharmacology focuses on deciphering the molecular mechanisms that control regeneration as well as tumor initiation and progression in epithelial tissues (https://www.uni
-
%). The Institute of Pharmacology focuses on deciphering the molecular mechanisms that control regeneration as well as tumor initiation and progression in epithelial tissues (https://www.uni-marburg.de/en/fb20
-
, researchers from some 60 countries study human biology – investigating the foundations of life from its most elementary building blocks to systems-wide mechanisms. By understanding what regulates or disrupts
-
! RESPONSIBILITIES: You will elucidate the molecular mechanisms driving the development of distinct malignant lymphoma subtypes and contribute to the identification of predictive biomarkers and novel therapeutic